Advertisement

Ads Placeholder
Loading...

Paion AG

PA8.DEXETRA
Healthcare
Drug Manufacturers - Specialty & Generic
0.36
0.02(4.35%)
German Market opens in 1h 3m

Paion AG Fundamental Analysis

Paion AG (PA8.DE) shows weak financial fundamentals with a PE ratio of -4.44, profit margin of -1.74%, and ROE of -8.51%. The company generates $0.0B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

Cash Position413.86%
PEG Ratio-0.04

Areas of Concern

ROE-8.51%
Operating Margin4.53%
We analyze PA8.DE's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -2.3/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-2.3/100

We analyze PA8.DE's fundamental strength across five key dimensions:

Efficiency Score

Weak

PA8.DE struggles to generate sufficient returns from assets.

ROA > 10%
-1.52%

Valuation Score

Excellent

PA8.DE trades at attractive valuation levels.

PE < 25
-4.44
PEG Ratio < 2
-0.04

Growth Score

Weak

PA8.DE faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Moderate

PA8.DE shows balanced financial health with some risks.

Debt/Equity < 1
3.08
Current Ratio > 1
1.41

Profitability Score

Weak

PA8.DE struggles to sustain strong margins.

ROE > 15%
-850.59%
Net Margin ≥ 15%
-1.74%
Positive Free Cash Flow
Yes

Key Financial Metrics

Is PA8.DE Expensive or Cheap?

P/E Ratio

PA8.DE trades at -4.44 times earnings. This suggests potential undervaluation.

-4.44

PEG Ratio

When adjusting for growth, PA8.DE's PEG of -0.04 indicates potential undervaluation.

-0.04

Price to Book

The market values Paion AG at 0.39 times its book value. This may indicate undervaluation.

0.39

EV/EBITDA

Enterprise value stands at -1.95 times EBITDA. This is generally considered low.

-1.95

How Well Does PA8.DE Make Money?

Net Profit Margin

For every $100 in sales, Paion AG keeps $-1.74 as profit after all expenses.

-1.74%

Operating Margin

Core operations generate 4.53 in profit for every $100 in revenue, before interest and taxes.

4.53%

ROE

Management delivers $-8.51 in profit for every $100 of shareholder equity.

-8.51%

ROA

Paion AG generates $-1.52 in profit for every $100 in assets, demonstrating efficient asset deployment.

-1.52%

Following the Money - Real Cash Generation

Operating Cash Flow

Paion AG produces operating cash flow of $6.27M, showing steady but balanced cash generation.

$6.27M

Free Cash Flow

Paion AG generates strong free cash flow of $4.59M, providing ample flexibility for dividends, buybacks, or growth.

$4.59M

FCF Per Share

Each share generates $0.61 in free cash annually.

$0.61

FCF Yield

PA8.DE converts 1.61% of its market value into free cash.

1.61%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-4.44

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.04

vs 25 benchmark

P/B Ratio

Price to book value ratio

0.39

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.08

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

3.08

vs 25 benchmark

Current Ratio

Current assets to current liabilities

1.41

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.09

vs 25 benchmark

ROA

Return on assets percentage

-0.02

vs 25 benchmark

ROCE

Return on capital employed

0.06

vs 25 benchmark

How PA8.DE Stacks Against Its Sector Peers

MetricPA8.DE ValueSector AveragePerformance
P/E Ratio-4.4428.54 Better (Cheaper)
ROE-8.51%738.00% Weak
Net Margin-1.74%-43982.00% (disorted) Weak
Debt/Equity3.080.34 Weak (High Leverage)
Current Ratio1.412806.01 Neutral
ROA-1.52%-14624.00% (disorted) Weak

PA8.DE outperforms its industry in 1 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Paion AG's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ